Catalyst Wire Dossier Catalyst Wire Dossier

Beta Hydroxybutyrate Ester

beta-hydroxybutyrate ester
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Beta Hydroxybutyrate Ester, covering 2024-05-08 to 2024-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of Beta Hydroxybutyrate Ester in Patients With Amyotrophic Lateral Sclerosis (ALS) [NA]

See pricing